ATE537819T1 - Nutrazeutische zusammensetzungen zur behandlung von muskelschwund - Google Patents
Nutrazeutische zusammensetzungen zur behandlung von muskelschwundInfo
- Publication number
- ATE537819T1 ATE537819T1 AT06806182T AT06806182T ATE537819T1 AT E537819 T1 ATE537819 T1 AT E537819T1 AT 06806182 T AT06806182 T AT 06806182T AT 06806182 T AT06806182 T AT 06806182T AT E537819 T1 ATE537819 T1 AT E537819T1
- Authority
- AT
- Austria
- Prior art keywords
- muscle wasting
- treating muscle
- nutraceutical compositions
- muscle
- nutraceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05022414 | 2005-10-14 | ||
EP06009943 | 2006-05-15 | ||
PCT/EP2006/009814 WO2007042271A2 (en) | 2005-10-14 | 2006-10-11 | Nutraceutical composition for the treatment of muscle wasting |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE537819T1 true ATE537819T1 (de) | 2012-01-15 |
Family
ID=37499262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06806182T ATE537819T1 (de) | 2005-10-14 | 2006-10-11 | Nutrazeutische zusammensetzungen zur behandlung von muskelschwund |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1937232B1 (de) |
JP (1) | JP2009511522A (de) |
KR (1) | KR20080105023A (de) |
CN (1) | CN101978958A (de) |
AT (1) | ATE537819T1 (de) |
ES (1) | ES2379810T3 (de) |
WO (1) | WO2007042271A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2551622A1 (en) * | 2005-07-07 | 2007-01-07 | H3 Formulations Ltd. | Dietary supplement for enhancing skeletal muscle mass, decreasing muscleprotein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
US20090162457A1 (en) * | 2005-10-26 | 2009-06-25 | Kao Corporation | Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
US20080070991A1 (en) * | 2006-03-24 | 2008-03-20 | Cella Charles H | Animal product enrichment using resveratrol |
KR101473017B1 (ko) * | 2006-07-05 | 2014-12-15 | 카오카부시키가이샤 | 노화 억제제 |
WO2009008991A2 (en) * | 2007-07-06 | 2009-01-15 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health | Dna-pkcs modulates energy regulation and brain function |
US20110112201A1 (en) * | 2008-04-17 | 2011-05-12 | Jiankang Liu | Hydroxytyrosol benefits mitochondria |
EP2418965B1 (de) | 2009-04-17 | 2016-06-29 | DSM IP Assets B.V. | Hydroxytyrosolkombinationen zur verstärkung der mitochondrienfunktion und energieproduktion |
JP5878016B2 (ja) * | 2009-09-18 | 2016-03-08 | 株式会社明治 | 筋拘縮予防剤 |
EP2501371A4 (de) * | 2009-10-07 | 2013-07-31 | Dsm Ip Assets Bv | Verwendung von hydroxytyrosol für verbesserte muskeldifferenzierung |
WO2012036168A1 (ja) * | 2010-09-14 | 2012-03-22 | 北海道公立大学法人札幌医科大学 | 筋ジストロフィーを処置するための組成物 |
ITMI20112093A1 (it) * | 2011-11-17 | 2013-05-18 | Lachifarma Srl Lab Chimico Farmaceutico Sa | Composizioni comprendenti idrossitirosolo e epigallocatechin gallato |
BR112015007131A2 (pt) | 2012-10-04 | 2017-07-04 | Abbott Lab | métodos para melhorar o efeito de egcg em atenuar a perda muscular esquelética |
MX2015013000A (es) | 2013-03-15 | 2015-12-01 | Abbott Lab | Metodos de mantenimiento y mejora de la funcion muscular. |
MY179576A (en) * | 2013-08-09 | 2020-11-11 | Suntory Holdings Limted | Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same |
WO2015094772A1 (en) * | 2013-12-18 | 2015-06-25 | Abbott Laboratories | Methods for increasing skeletal muscle protein synthesis using green tea extract |
WO2015094767A1 (en) * | 2013-12-18 | 2015-06-25 | Abbott Laboratories | Methods for maintaining or increasing bodyweight using decaffeinated green tea extract |
EP3635115A1 (de) * | 2017-06-09 | 2020-04-15 | Vib Vzw | Glutamin-dehydrogenase-inhibitoren zur verwendung in der muskelregeneration |
CN107811997A (zh) * | 2017-11-10 | 2018-03-20 | 大连医科大学附属第医院 | 蛋白酶体抑制剂白藜芦醇在预防和治疗心血管疾病中的应用 |
CN111315239A (zh) * | 2017-11-21 | 2020-06-19 | 雀巢产品有限公司 | 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法 |
CA3175049A1 (en) * | 2020-03-10 | 2021-04-15 | The Regents Of The University Of California | Novel nutrients to enhance load-induced muscle hypertrophy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5335192B2 (ja) * | 2003-05-27 | 2013-11-06 | ディーエスエム アイピー アセッツ ビー.ブイ. | 新規栄養補助食品組成物及びその使用 |
CA2551622A1 (en) * | 2005-07-07 | 2007-01-07 | H3 Formulations Ltd. | Dietary supplement for enhancing skeletal muscle mass, decreasing muscleprotein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
JPWO2007020917A1 (ja) * | 2005-08-18 | 2009-02-26 | 国立大学法人徳島大学 | ユートロフィン産生の増強持続剤とこれを用いる加工食品 |
-
2006
- 2006-10-11 CN CN2010105185792A patent/CN101978958A/zh active Pending
- 2006-10-11 JP JP2008534923A patent/JP2009511522A/ja active Pending
- 2006-10-11 WO PCT/EP2006/009814 patent/WO2007042271A2/en active Application Filing
- 2006-10-11 ES ES06806182T patent/ES2379810T3/es active Active
- 2006-10-11 AT AT06806182T patent/ATE537819T1/de active
- 2006-10-11 EP EP06806182A patent/EP1937232B1/de not_active Not-in-force
- 2006-10-11 KR KR1020087008683A patent/KR20080105023A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2009511522A (ja) | 2009-03-19 |
ES2379810T3 (es) | 2012-05-03 |
EP1937232A2 (de) | 2008-07-02 |
WO2007042271A3 (en) | 2008-02-14 |
EP1937232B1 (de) | 2011-12-21 |
KR20080105023A (ko) | 2008-12-03 |
WO2007042271A2 (en) | 2007-04-19 |
CN101978958A (zh) | 2011-02-23 |
WO2007042271A8 (en) | 2008-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE537819T1 (de) | Nutrazeutische zusammensetzungen zur behandlung von muskelschwund | |
BRPI0518334A2 (pt) | composiÇço de revestimento, mÉtodo de revestimento, revestimento, e, mÉtodo para preparar uma composiÇço de revestimento | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
SE0301010D0 (sv) | Novel compounds | |
ATE495743T1 (de) | Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
SE0301009D0 (sv) | Novel compounds | |
BRPI0717219A2 (pt) | "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica." | |
AR050717A1 (es) | Composiciones farmaceuticas | |
TW200732296A (en) | Novel compounds | |
HK1133787A1 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
CL2011000527A1 (es) | Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c. | |
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
HN2006000971A (es) | Metodos para preparar composiciones o formas de dosificacion que comprenden un agonista grp119 que tiene el efecto de un secretagogo glp-1 | |
TW200612892A (en) | Novel compounds | |
ATE492542T1 (de) | Herstellung und anwendung von biphenyl-4-yl- carbonylaminosäurederivaten zur behandlung von obesitas | |
UY29079A1 (es) | Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
TW200630336A (en) | Novel compounds | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
MX2009003911A (es) | Formulaciones de liberacion inmediata, mejoradas de topiramato. | |
TW200745003A (en) | Novel compounds | |
WO2007109172A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2007109160A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2007109154A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
BRPI0713447A2 (pt) | composição forma de dosagem oral sólida, e, método para o tratamento de dor |